Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Income (2020 - 2025)

Historic Net Income for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • Biofrontera's Net Income fell 1728.7% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 3688.56%. This contributed to the annual value of -$17.8 million for FY2024, which is 1178.28% up from last year.
  • Per Biofrontera's latest filing, its Net Income stood at -$6.6 million for Q3 2025, which was down 1728.7% from -$5.3 million recorded in Q2 2025.
  • Biofrontera's Net Income's 5-year high stood at $5.6 million during Q1 2022, with a 5-year trough of -$16.0 million in Q3 2021.
  • In the last 5 years, Biofrontera's Net Income had a median value of -$4.2 million in 2025 and averaged -$4.9 million.
  • Per our database at Business Quant, Biofrontera's Net Income skyrocketed by 25735.71% in 2022 and then crashed by 197159.53% in 2025.
  • Over the past 5 years, Biofrontera's Net Income (Quarter) stood at -$14.5 million in 2021, then soared by 80.8% to -$2.8 million in 2022, then skyrocketed by 226.61% to $3.5 million in 2023, then plummeted by 139.59% to -$1.4 million in 2024, then plummeted by 376.29% to -$6.6 million in 2025.
  • Its last three reported values are -$6.6 million in Q3 2025, -$5.3 million for Q2 2025, and -$4.2 million during Q1 2025.